Olmetrack CT 40/12.5 Tablet
Marketer
USV Ltd
Salt Composition
Olmesartan Medoxomil (40mg) + Chlorthalidone (12.5mg)
Overview Olmetrack CT 40/12.5 Tablet
Olmetrack CT 40/12.5mg tablets combine two medications to manage hypertension through complementary mechanisms. Untreated high blood pressure significantly increases the risk of serious complications such as strokes, heart attacks, and kidney damage. This medication can be taken with or without food, with dosage adjusted based on individual response and health status. Consistent daily dosing is crucial; discontinue only under your physician's guidance. As it includes a diuretic, increased urination is expected; avoid taking it within four hours of bedtime. Continuous use, even during asymptomatic periods, is essential to maximize therapeutic benefits and mitigate the increased risk of stroke or heart attack associated with treatment discontinuation. Common side effects include dizziness, fatigue, nausea, diarrhea, headache, and reduced blood pressure. Increased urination is a desired effect of the chlorthalidone component, contributing to blood pressure control. While other side effects are possible, most are uncommon. Consult the patient information leaflet and inform your doctor about any persistent or bothersome side effects; dosage adjustments or alternative treatments may be considered. Use during pregnancy is discouraged, and prior consultation is advised for individuals with kidney or liver disease, cardiac conditions, or diabetes. Alcohol consumption can exacerbate blood pressure reduction and potential side effects.
Primary Ingredients of Olmetrack CT 40/12.5 Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Olmetrack CT 40/12.5 Tablet
Elevated blood pressure
Major Benefits of Olmetrack CT 40/12.5 Tablet:
Consume Olmetrack CT 40/12.5 Tablet as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. While this medication can be administered with or without food, consistent daily timing is recommended.
Common Side effects of Olmetrack CT 40/12.5 Tablet:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Weakness
- Headache
- Increased blood uric acid
- Dizziness
- Increased blood lipid level
- Electrolyte imbalance
- Decreased blood pressure
- Urinary tract infection
- Renal dysfunction
- Sore throat
- Abnormal liver function tests
- Increased potassium level in blood
How to use Olmetrack CT 40/12.5 Tablet:
Consume Olmetrack CT 40/12.5 tablets precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, though consistent timing is recommended.
How Olmetrack CT 40/12.5 Tablet works:
Each Olmetrack CT 40/12.5 tablet contains a dual medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Olmetrack CT 40/12.5mg tablets and alcohol can result in heightened somnolence.
PregnancyCONSULT YOUR DOCTOR
Using Olmetrack CT 40/12.5 tablets during pregnancy poses a confirmed risk to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Olmetrack CT 40/12.5 Tablet while breastfeeding is likely unsafe. Preliminary human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Olmetrack CT 40/12.5 Tablets might reduce alertness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should use Olmetrack CT 40/12.5 Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised; its use is generally discouraged in such cases.
LiverCAUTION
Patients with hepatic impairment should use Olmetrack CT 40/12.5 Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. Olmetrack CT 40/12.5 Tablet is contraindicated in individuals with severe liver disease.
What if you forget to take Olmetrack CT 40/12.5 Tablet :
Should you forget to take your Olmetrack CT 40/12.5 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmetrack CT 40/12.5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |





